Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Standard Septic Shock Treatments Ineffective

Studies find corticosteroids, insulin don't combat mortality

By Serena Gordon
HealthDay Reporter


Related Encyclopedia
 border=
Abscess
Actinomycosis
Acute Myeloid Leukemia (Adult)
Addison's Disease
More...

Related Healthscout Videos
 border=
Fighting HIV and AIDS: New Research
Blood Cleaner
Natural Treatment for Autoimmune Disease
New AIDS Drugs
More...

Related Animations
 border=
Diabetes
More...

Related Drug Information
 border=
Abilify
Actonel
Actos
Amaryl
More...

Related News Articles
 border=
Lingering Cold Symptoms May Mean Sinusitis
To Protect Yourself, Wash Those Germs Away
Dubious Drugs, Tainted Foods Top 2008's Health Stories
Preventive Use of Antibiotics Cuts ICU Deaths
More...

WEDNESDAY, Jan. 9 (HealthDay News) -- Two new studies on the treatment of septic shock question the conventional wisdom of treating with corticosteroids, intensive insulin therapy or with the synthetic fluid replacement substance called pentastarch.

The first study compared the use of hydrocortisone to a placebo in people in septic shock and found no improvement in survival rates.

Text Continues Below



The second study looked at the use of intensive insulin therapy versus a placebo, and the use of pentastarch to the more commonly used Ringer's lactate, which is saline with added lactate, chloride, potassium and calcium. Both intensive insulin and pentastarch failed to improve survival rates, and, in fact, increased the rates of serious complications so much that the trial was stopped early.

Results of both studies are published in the Jan. 10 issue of the New England Journal of Medicine.

Septic shock is "associated with significant morbidity and mortality. Standard treatment for septic shock includes antibiotics, intravenous fluids and vasopressor medicines (drugs to increase blood pressure)," explained the first study's lead author, Dr. Charles Sprung, director of the general intensive care unit, department of anesthesiology and critical care medicine at Hadassah Hebrew University Medical Center in Israel. "Until our study, doctors in hospitals around the world were also routinely using steroids as adjunct therapy to help hundreds of thousands of patients in septic shock fight for their lives. Our study demonstrates that this adjunct therapy of hydrocortisone is not helpful for most patients with septic shock and, in fact, may be harmful."

Septic shock occurs when an infection, usually bacterial, overwhelms the body's natural defenses, according to the U.S. National Institutes of Health. The major symptoms include low blood pressure and low blood flow. If not effectively treated, failure of the kidneys, liver, brain and heart may occur. Septic shock is a life-threatening condition.

Page:  1 | 2 | 3 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 1/9/2008

Related Links
 border=
From Healthscout's partner site on diabetes, MyDiabetesCentral.com
UNDERSTAND: Learn the differences between Type 1 and Type 2
DRUGS: Common drugs used to treat diabetes
DIET: Eating right can save your life!





SOURCES: Frank Brunkhorst, M.D., senior physician, internal and intensive care medicine, the Clinic for Anesthesiology and Intensive Care, Friedrich Schiller University of Jena, Germany; Charles Sprung, M.D., director, general intensive care unit, department of anesthesiology and critical care medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel; Louis Saravolatz, M.D., chairman, department of medicine, St. John Hospital and Medical Center, Detroit; Jan. 10, 2008, New England Journal of Medicine


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map